Dare Bioscience, Inc. (DARE) vs Lisata Therapeutics, Inc. (LSTA)
A side-by-side comparison of Dare Bioscience, Inc. and Lisata Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DARE
Dare Bioscience, Inc.
$0.83HealthcareDelayed quote: Oct 6, 2026, 10:23 AM EDT
LSTA
Lisata Therapeutics, Inc.
$1.25HealthcareDelayed quote: Oct 6, 2026, 10:24 AM EDT
Total return — DARE vs LSTA
growth of $100 · dividends reinvested · last 10yDARE -99.3% (-39.1%/yr)LSTA -98.2% (-32.9%/yr)LSTA compounded faster over this window
DARE LSTA
DARE vs LSTA: by the numbers
- •DARE is the larger company ($12M vs $11M market cap).
- •Both run net losses; DARE's is the smaller (-804.37% vs -14621.00% net margin).
Metrics side by side
Valuation
| Metric | DARE | LSTA |
|---|---|---|
| P/S ratio | 9.12 | 113.83 |
| P/B ratio | N/A | 1.38 |
Profitability
| Metric | DARE | LSTA |
|---|---|---|
| Gross margin | -137.55% | 14.12% |
| Operating margin | -1315.51% | -10711.18% |
| Net margin | -804.37% | -14621.00% |
| ROE | N/A | -177.35% |
| ROIC | -203.50% | -204.32% |
Growth (annualized)
| Metric | DARE | LSTA |
|---|---|---|
| Total return CAGR (5Y) | -46.35% | -40.75% |
Frequently asked
- How have DARE and LSTA total returns compared?
- Over the past 10 years, DARE delivered -39.10% and LSTA delivered -32.84% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.